INVION LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 AUD | -.--% |
|
-.--% | -.--% |
| Mar. 05 | Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results | MT |
| Feb. 27 | Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Quotes 5-day view
Delayed Quote Australian S.E.| 2024-04-23 | 2024-04-24 | 2024-04-29 | 2024-04-30 | |
|---|---|---|---|---|
| Last | 0.006 $ | 0.006 $ | 0.005 $ | 0.005 $ |
| Volume | 304 457 | 50 000 | 11 819 | 725 000 |
| Change | +20.00% | -.--% | -16.67% | -.--% |
| Opening | 0.01 | 0.01 | 0.01 | 0.01 |
| High | 0.01 | 0.01 | 0.01 | 0.01 |
| Low | 0.01 | 0.01 | 0.01 | 0.01 |
Performance
| Current month | -16.67% | ||
| 1 month | -16.67% | ||
| 3 months | +25.00% | ||
| 6 months | -28.57% | ||
| 1 year | -28.57% | ||
| 3 years | -44.44% | ||
| 5 years | -72.22% | ||
| 10 years | -92.54% |
Volumes
marketsDaily volume
725 000
Estimated daily volume
725 000
Avg. Volume 20 sessions
363 268
Daily volume ratio
2.00
Avg. Volume 20 sessions AUD
1 816.34
Avg. Volume 20 sessions USD
1 186.16
Record volume 1
498 430 000
Record volume 2
123 885 000
Record volume 3
123 264 000
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (AUD)
31 942 769
Capitalization (USD)
20 860 225
Net sales (AUD)
4 104 711
Net sales (USD)
2 680 582
Number of employees
4
Sales / Employee (AUD)
1 026 178
Sales / Employee (USD)
670 145
Free-Float
50.95 %
Free-Float capitalization (AUD)
16 267 471
Free-Float capitalization (USD)
10 623 472
Average Daily Capital Traded
0.01%
Highs and lows
1 week
0.01
0.01
1 month
0.010.01
Current year
0.000.01
1 year
0.000.01
3 years
0.000.03
5 years
0.000.03
10 years
0.000.09
Indicators
Moving average 5 days
0.01
Moving average 20 days
0.01
Moving average 50 days
0.01
Moving average 100 days
0.01
Price spread / (MMA5)
+10.00%
Price spread / (MMA20)
+8.00%
Price spread / (MMA50)
-.--%
Price spread / (MMA100)
+2.00%
STIM
RSI 9 days
45.79
RSI 14 days
47.83
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -.--% | -.--% | -.--% | -28.57% | 20.86M | ||
| +0.50% | -2.38% | +0.67% | +23.75% | 42.19B | ||
| -2.30% | +0.71% | +44.30% | -7.84% | 40.15B | ||
| +2.89% | +5.76% | -6.20% | +17.68% | 28.31B | ||
| +1.25% | -1.58% | +6.55% | +56.53% | 24.63B | ||
| +4.18% | +2.66% | -21.66% | -24.72% | 18.2B | ||
| +2.58% | -2.16% | +29.96% | +99.05% | 12.01B | ||
| +1.61% | -3.10% | -1.57% | +22.39% | 11.76B | ||
| +8.88% | +8.82% | +16.03% | +10.87% | 10.4B | ||
| +16.22% | +15.34% | -4.80% | -8.04% | 9.94B | ||
| +1.13% | +2.20% | -4.38% | -6.91% | 9.39B | ||
| -0.94% | +18.86% | +7.53% | -35.02% | 6.6B | ||
| -1.29% | +2.23% | +23.31% | -17.46% | 6.56B | ||
| +4.09% | +7.02% | +35.30% | +65.20% | 6.36B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| +4.24% | +2.80% | -14.98% | +21.60% | 6.02B | ||
| Average | +2.69% | -1.12% | +7.34% | +12.57% | ||
| Weighted average by Cap. | +1.96% | -0.90% | +9.27% | +16.12% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -.--% | ||
| 2023 | -44.44% | ||
| 2022 | -57.14% | ||
| 2021 | +110.00% | ||
| 2020 | -23.08% | ||
| 2019 | -27.78% | ||
| 2018 | +200.00% | ||
| 2017 | +200.00% | ||
| 2016 | -66.67% | ||
| 2015 | -87.23% | ||
| 2014 | -44.05% | ||
| 2013 | +47.37% | ||
| 2012 | -9.52% | ||
| 2011 | -70.70% | ||
| 2010 | -45.57% |
- Stock Market
- Equities
- IVX Stock
- Quotes Invion Limited
